(WATCH) FDA does an about-face; requests investigation of Alzheimer drug approval

After originally defending her agency’s process, FDA acting commissioner Janet Woodcock has now requested a review of the FDA’s controversial approval of an Alzheimer’s drug. There has been widespread criticism of last month’s approval of aducanumab sold under the brand name Aduhelm. The FDA gave the injectable medicine a green light in June even though […]

Share DeepPol